Dr. Leslie E. Botnick, MD

Dr. Botnick practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Botnick's NPI, 1275530917, was assigned on July 7, 2005. Dr. Botnick graduated from New York Medical College in 1972. Dr. Botnick holds California license G37645.

Dr. Botnick's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (626) 256-4673.

Dr. Botnick's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Botnick to 7 more medical groups, 6 group practices and clinics and 2 physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Botnick practices, 8 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Botnick's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Botnick is board certified in therapeutic radiology by the American Board of Radiology. Dmand AI has Dr. Botnick's licenses on file in 8 states: California, New York, Arizona, Massachusetts, Ohio, Illinois, Colorado and New Mexico.

Dmand AI lists breast cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Botnick treats.

CMS data shows 1,135 Medicare services from Dr. Botnick across 11 procedure codes in 2024, for 109 Medicare patients. Medicare paid $232,949 for them.

CMS counts 109 Medicare patients who saw Dr. Botnick in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have cancer, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Botnick's median patient age at 68, with 59% women.

In 2024, Dr. Botnick wrote 22 Medicare Part D claims for 12 patients. 95% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $378 in total drug cost. In 2019, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Botnick for performance year 2024, reported as part of a group. Dr. Botnick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Dr. Botnick in 2016. The most frequent topics are Hematopoietic Stem Cells, Cell Division and Antineoplastic Agents. Dr. Botnick has published most often in Int J Radiat Oncol Biol Phys. Dr. Botnick's most frequent co-authors are Christopher M. Rose, MD, Robert Clinton Bast, MD and George Peter Canellos, MD.

CMS Open Payments shows 13 general payments to Dr. Botnick from 9 drug and device companies from 2017 to 2025. Debt forgiveness make up the largest share, 92% of the total. Olympus America Inc. paid the most, $6,466.

Dr. Botnick graduated from New York Medical College in 1972.

Dr. Botnick is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.